Latest Articles

Publication Date
All News Scientific
Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report - Dove Medical Press

Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report Dove Medical Press

Published: Dec. 11, 2024, 7:09 a.m.
Read Full Article
Dermatologist Warns: Laptops And Heating Pads May Cause Permanent Skin Damage; Know About Toasted Skin Syndrome - Medical Daily

Dermatologist Warns: Laptops And Heating Pads May Cause Permanent Skin Damage; Know About Toasted Skin Syndrome Medical Daily

Published: Dec. 11, 2024, 6:20 a.m.
Read Full Article
An Unusual Case of Pelvic Congestion Syndrome: A Case Report - Cureus

An Unusual Case of Pelvic Congestion Syndrome: A Case Report Cureus

Published: Dec. 11, 2024, 4:33 a.m.
Read Full Article
The Bayer class action decision shows women’s pain is still not taken seriously - Body+Soul

The Bayer class action decision shows women’s pain is still not taken seriously Body+Soul

Published: Dec. 11, 2024, 3:46 a.m.
Read Full Article
Monash Endometriosis research receives support from Spanish media fundraiser - Monash University

Monash Endometriosis research receives support from Spanish media fundraiser Monash University

Published: Dec. 11, 2024, 2:56 a.m.
Read Full Article
Women and girls left to ‘suck it up’ as health conditions dismissed – report - Jersey Evening Post

Women and girls left to ‘suck it up’ as health conditions dismissed – report Jersey Evening Post

Published: Dec. 11, 2024, 12:06 a.m.
Read Full Article
"What is Airbnb?": List of top 10 questions Kenyans asked Google in 2024 - Tuko.co.ke

"What is Airbnb?": List of top 10 questions Kenyans asked Google in 2024 Tuko.co.ke

Published: Dec. 10, 2024, 12:45 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!